Skip to main content

Ana Zabalza de Torres

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Ana Zabalza de Torres

Institutions of which they are part

Postdoctoral researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Liquid biopsy in multiple sclerosis: A non-invasive approach for disease prognosis and drug discovery...

IP: Liquid biopsy in multiple sclerosis: A non-invasive approach for disease prognosis and drug discovery...
Collaborators: Jordi Rio Izquierdo, Ana Zabalza de Torres, Rucsanda Pinteac, Rucsanda Pinteac
Funding agency: Instituto de Salud Carlos III
Funding: 140360
Reference: PI20/01697
Duration: 01/01/2021 - 30/06/2025

TRAtamiento y recuperación VISual en neuritis óptica - Estudio TRAVIS

IP: Jaume Sastre Garriga
Collaborators: Dulce María Moncho Rodríguez, Sergio Cabello, Cristina Auger Acosta, Alex Rovira Cañellas, Ana Zabalza de Torres, Joaquin Castillo Justribo
Funding agency: Instituto de Salud Carlos III
Funding: 96800
Reference: PI19/00950
Duration: 01/01/2020 - 30/06/2024

Remote Assessment of Disease and Relapse in Central Nervous System Disorders (RADAR-CNS)

IP: Remote Assessment of Disease and Relapse in Central Nervous System Disorders (RADAR-CNS)
Collaborators: Carlos Nos Llopis, Gabriel Ig Camiña Rodríguez, Ana Zabalza de Torres, Luciana Midaglia Fernandez
Funding agency: The Innovative Medicines Initiative
Funding: 552235
Reference: RADAR_IMI2015
Duration: 01/04/2016 - 31/03/2022

Related news

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

Related professionals

M Teresa Martin Gomez

M Teresa Martin Gomez

Senior researcher
Microbiology
Read more
Sergi Torramadé Moix

Sergi Torramadé Moix

Postdoctoral researcher
Transfusional Medicine
Read more
Miguel Angel Sandonis Vicente

Miguel Angel Sandonis Vicente

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more
Sara Palacin i Bonson

Sara Palacin i Bonson

Research technician
Neurodegenerative Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.